Difference between revisions of "Comment Resolutions"
Jump to navigation
Jump to search
m |
m |
||
Line 65: | Line 65: | ||
| | | | ||
| | | | ||
− | | | + | |'''Public Comments were resolved for Version 1. There was no Public Comment for version 2, as it is an update of version 1.''' |
| | | | ||
|- | |- |
Revision as of 18:43, 10 June 2020
Comments received during Public Comment, Technical Confirmation, or during a Profile ballot, are reviewed by the originating Biomarker Committee.
Per the QIBA Process, committees record how each collected comment was resolved and those resolutions are posted here.
Profile Document | Feedback Type | Feedback Closed | Resolutions | ||
---|---|---|---|---|---|
CT Profiles | |||||
CT Atherosclerosis 2020-03-10 | Public Comment | 2019.06.03 | Public Comment Resolutions 2020-03-12 | ||
CT Tumor Volumetry for Advanced Disease 2016-11-21b | Technical Confirmation | 2017.02 | Technical Confirmation Resolutions | ||
CT Small Lung Nodule Screening 2018-11-18 | Technical Confirmation | 2020.04 | TBA | ||
CT Small Lung Nodule Screening 2016-06-01 | Public Comment | 2016.09 | TBA | ||
MR Profiles | |||||
MR DWI 2019-02-05 | Public Comment #2 | 2019.04.05 | Public Comment Resolutions | ||
fMRI Sensorimotor 2017-06-19 | Public Comment | 2017.12.31 | TBA | ||
MR Elastography 2017-08-15 | Public Comment | 2017.09.15 | TBA | ||
MR DWI 2017-04-27 | Public Comment | 2017.08.25 | TBA | ||
PET/NM Profiles | |||||
PET Amyloid 2019-06-15 | Public Comment | 2017.09.15 | TBA | ||
SPECT Ioflupane in Neurodegenerative Disease v2.0, 2019-10-15 | Public Comment | Public Comments were resolved for Version 1. There was no Public Comment for version 2, as it is an update of version 1. | |||
99mTC SPECT 2020-05-12 | Public Comment Resolutions | 2020.02.03 | Public Comment Resolutions 2020-05-12 |